Global Digital PCR and Real-time PCR (qPCR) Market

1 INTRODUCTION OF GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR)MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR)MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR) MARKET, BY PRODUCT AND SERVICES
5.1 dPCR Products and Services
5.1.1 dPCR Instruments
5.1.2 dPCR Reagents and Consumables
5.1.3 dPCR Software and Services
5.2 qPCR Products and Services
5.2.1 qPCR Reagents and Consumables
5.2.2 qPCR Instruments
5.2.3 qPCR Software and Services

6 GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR) MARKET, BY TECHNOLOGY
6.1 Quantitative PCR (qPCR)
6.2 Digital PCR (dPCR)

7 GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR) MARKET, BY END USER
7.1 Digital PCR (dPCR) End Users
7.1.1 Research Laboratories and Academic Institutes
7.1.2 Hospitals and Diagnostic Centers
7.1.3 Pharmaceutical and Biotechnology Companies
7.1.4 Clinical Research Organizations
7.1.5 Forensic Laboratories
7.2 Quantitative PCR (qPCR) End Users
7.2.1 Hospitals and Diagnostic Centers
7.2.2 Research Laboratories and Academic Institutes
7.2.3 Pharmaceutical and Biotechnology Companies
7.2.4 Clinical Research Organizations
7.2.5 Forensic Laboratories

8 GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR) MARKET, BY APPLICATION
8.1 qPCR and dPCR applications
8.1.1 Clinical Applications
8.1.1.1 Pathogen Testing
8.1.1.2 Oncology Testing
8.1.1.3 Blood Screening
8.1.1.4 Other Clinical Applications
8.1.2 Research Applications
8.1.3 Forensic Applications
9 GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR)MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL DIGITAL PCR AND REAL-TIME PCR (QPCR)MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 F. Hoffman-La Roche Ltd.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Thermo Fisher Scientific, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Bio-Rad Laboratories, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Qiagen N.V.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Takara Bio, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Agilent Technologies, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Biomérieux S.A.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Fluidigm Corporation
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Danaher Corporation
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 ABBott Laboratories
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Merck KGaA
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

11.12 Becton Dickinson and Company
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 Promega Corporation
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

11.14 Meridian Bioscience, Inc. (Bioline Reagents Ltd.)
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments

11.15 Analytik Jena AG (Endress+Hauser Ag)
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments

12 Appendix
12.1 Related Reports